147 related articles for article (PubMed ID: 38066369)
1. Use of Galleria mellonella as an Animal Model for Studying the Antimicrobial Activity of Bacteriophages with Potential Use in Phage Therapy.
Blasco L; Tomás M
Methods Mol Biol; 2024; 2734():171-180. PubMed ID: 38066369
[TBL] [Abstract][Full Text] [Related]
2. Galleria mellonella infection models for the study of bacterial diseases and for antimicrobial drug testing.
Tsai CJ; Loh JM; Proft T
Virulence; 2016 Apr; 7(3):214-29. PubMed ID: 26730990
[TBL] [Abstract][Full Text] [Related]
3. The comparison of lytic activity of isolated phage and commercial Intesti bacteriophage on ESBL producer E. coli and determination of Ec_P6 phage efficacy with in vivo Galleria mellonella larvae model.
Erol HB; Kaskatepe B; Ozturk S; Safi Oz Z
Microb Pathog; 2022 Jun; 167():105563. PubMed ID: 35513294
[TBL] [Abstract][Full Text] [Related]
4. New Bacteriophages against Emerging Lineages ST23 and ST258 of
Thiry D; Passet V; Danis-Wlodarczyk K; Lood C; Wagemans J; De Sordi L; van Noort V; Dufour N; Debarbieux L; Mainil JG; Brisse S; Lavigne R
Viruses; 2019 May; 11(5):. PubMed ID: 31058805
[No Abstract] [Full Text] [Related]
5. Efficacy of bacteriophage treatment against carbapenem-resistant Acinetobacter baumannii in Galleria mellonella larvae and a mouse model of acute pneumonia.
Jeon J; Park JH; Yong D
BMC Microbiol; 2019 Apr; 19(1):70. PubMed ID: 30940074
[TBL] [Abstract][Full Text] [Related]
6. Design of a Broad-Range Bacteriophage Cocktail That Reduces Pseudomonas aeruginosa Biofilms and Treats Acute Infections in Two Animal Models.
Forti F; Roach DR; Cafora M; Pasini ME; Horner DS; Fiscarelli EV; Rossitto M; Cariani L; Briani F; Debarbieux L; Ghisotti D
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29555626
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic potential of bacteriophages targeting gram-negative bacteria using Galleria mellonella infection model.
Manohar P; Nachimuthu R; Lopes BS
BMC Microbiol; 2018 Aug; 18(1):97. PubMed ID: 30170558
[TBL] [Abstract][Full Text] [Related]
8. Bacteriophage cocktail shows no toxicity and improves the survival of
Kelly L; Jameson E
J Virol; 2024 Jun; 98(6):e0027224. PubMed ID: 38771043
[No Abstract] [Full Text] [Related]
9. Antibiotics Act with vB_AbaP_AGC01 Phage against
Grygorcewicz B; Roszak M; Golec P; Śleboda-Taront D; Łubowska N; Górska M; Jursa-Kulesza J; Rakoczy R; Wojciuk B; Dołęgowska B
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32575645
[TBL] [Abstract][Full Text] [Related]
10. Efficacy in Galleria mellonella Larvae and Application Potential Assessment of a New Bacteriophage BUCT700 Extensively Lyse Stenotrophomonas maltophilia.
Li Y; Pu M; Han P; Li M; An X; Song L; Fan H; Chen Z; Tong Y
Microbiol Spectr; 2023 Feb; 11(1):e0403022. PubMed ID: 36700630
[TBL] [Abstract][Full Text] [Related]
11. The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis.
Ramarao N; Nielsen-Leroux C; Lereclus D
J Vis Exp; 2012 Dec; (70):e4392. PubMed ID: 23271509
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of bacteriophage therapy against Cronobacter sakazakii in Galleria mellonella (greater wax moth) larvae.
Abbasifar R; Kropinski AM; Sabour PM; Chambers JR; MacKinnon J; Malig T; Griffiths MW
Arch Virol; 2014 Sep; 159(9):2253-61. PubMed ID: 24705602
[TBL] [Abstract][Full Text] [Related]
13. A Multiwell-Plate Caenorhabditis elegans Assay for Assessing the Therapeutic Potential of Bacteriophages against Clinical Pathogens.
Manohar P; Loh B; Elangovan N; Loganathan A; Nachimuthu R; Leptihn S
Microbiol Spectr; 2022 Feb; 10(1):e0139321. PubMed ID: 35171008
[TBL] [Abstract][Full Text] [Related]
14. Experimental bacteriophage therapy increases survival of Galleria mellonella larvae infected with clinically relevant strains of the Burkholderia cepacia complex.
Seed KD; Dennis JJ
Antimicrob Agents Chemother; 2009 May; 53(5):2205-8. PubMed ID: 19223640
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Galleria mellonella larvae for studying the virulence of Streptococcus suis.
Velikova N; Kavanagh K; Wells JM
BMC Microbiol; 2016 Dec; 16(1):291. PubMed ID: 27978817
[TBL] [Abstract][Full Text] [Related]
16. Characterization and Comparative Genomics Analysis of a New Bacteriophage BUCT610 against
Pu M; Han P; Zhang G; Liu Y; Li Y; Li F; Li M; An X; Song L; Chen Y; Fan H; Tong Y
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887393
[TBL] [Abstract][Full Text] [Related]
17. Utility of Greater Wax Moth Larva (Galleria mellonella) for Evaluating the Toxicity and Efficacy of New Antimicrobial Agents.
Desbois AP; Coote PJ
Adv Appl Microbiol; 2012; 78():25-53. PubMed ID: 22305092
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of newly isolated and highly potent bacteriophages in a mouse model of extensively drug-resistant Acinetobacter baumannii bacteraemia.
Leshkasheli L; Kutateladze M; Balarjishvili N; Bolkvadze D; Save J; Oechslin F; Que YA; Resch G
J Glob Antimicrob Resist; 2019 Dec; 19():255-261. PubMed ID: 31100499
[TBL] [Abstract][Full Text] [Related]
19. The Use of Galleria mellonella (Wax Moth) as an Infection Model for Group A Streptococcus.
Tsai CJ; Loh JMS; Proft T
Methods Mol Biol; 2020; 2136():279-286. PubMed ID: 32430829
[TBL] [Abstract][Full Text] [Related]
20. Bacteriophage-antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model.
Wang L; Tkhilaishvili T; Bernal Andres B; Trampuz A; Gonzalez Moreno M
Int J Antimicrob Agents; 2020 Dec; 56(6):106200. PubMed ID: 33075514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
